Do markers of bone turnover predict clinical outcome in patients with bone metastases?

被引：0
作者：
Guise, TA [1 ]
机构：
[1] Univ Virginia, Dept Med, Div Endocrinol & Metab, Charlottesville, VA 22908 USA
来源：
NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM | 2006年 / 2卷 / 05期
关键词：
bisphosphonate; bone metastases; bone-specific alkaline phosphatase; N-telopeptide of type I collagen; solid tumor;
D O I：
10.1038/ncpendmet0171
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：258 / 259
页数：2
相关论文
共 50 条
[21]   Bone turnover markers as predictive indicators of outcome in patients with breast cancer and bone metastases treated with bisphosphonates: Results from a 2-year multicentre observational study (ZOMAR study) [J].
Barnadas, Agusti ;
Manso, Luis ;
de la Piedra, Concepcion ;
Meseguer, Cristina ;
Crespo, Carmen ;
Gomez, Patricia ;
Calvo, Lourdes ;
Martinez, Purificacion ;
Ruiz-Borrego, Manuel ;
Perello, Antonia ;
Anton, Antonio ;
Codes, Manuel ;
Margeli, Mireia ;
Murias, Adolfo ;
Salvador, Javier ;
Angel Segui, Miguel ;
de Juan, Ana ;
Gavila, Joaquin ;
Luque, Maria ;
Perez, Diego ;
Zamora, Pilar ;
Arizcuma, Alberto ;
Ignacio Chacon, Jose ;
Heras, Lucia ;
Martin-Fernandez, Marta ;
Mahillo-Fernandez, Ignacio ;
Tusquets, Ignacio .
BONE, 2014, 68 :32-40
[22]   Novel diagnostic model for bone metastases in renal cell carcinoma patients based on bone scintigraphy analyzed by computer-aided diagnosis software and bone turnover markers [J].
Takeshi Ujike ;
Motohide Uemura ;
Taigo Kato ;
Koji Hatano ;
Atsunari Kawashima ;
Akira Nagahara ;
Kazutoshi Fujita ;
Ryoichi Imamura ;
Norio Nonomura .
International Journal of Clinical Oncology, 2022, 27 :774-780
[23]   Diagnostic value of bone-turnover metabolites in the diagnosis of bone metastases in patients with lung carcinoma [J].
Izumi, M ;
Nakanishi, Y ;
Takayama, K ;
Kimotsuki, K ;
Inoue, K ;
Wataya, H ;
Minami, T ;
Hara, N .
CANCER, 2001, 91 (08) :1487-1493
[24]   Novel diagnostic model for bone metastases in renal cell carcinoma patients based on bone scintigraphy analyzed by computer-aided diagnosis software and bone turnover markers [J].
Ujike, Takeshi ;
Uemura, Motohide ;
Kato, Taigo ;
Hatano, Koji ;
Kawashima, Atsunari ;
Nagahara, Akira ;
Fujita, Kazutoshi ;
Imamura, Ryoichi ;
Nonomura, Norio .
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2022, 27 (04) :774-780
[25]   Diagnostic value of bone remodeling markers in the diagnosis of bone metastases in patients with breast cancer [J].
Pectasides, D ;
Farmakis, D ;
Nikolaou, M ;
Kanakis, I ;
Kostopoulou, V ;
Papaconstantinou, I ;
Karamanos, NK ;
Economopoulos, T ;
Raptis, SA .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2005, 37 (01) :171-176
[26]   Retrospective Evaluation of Bone Turnover Markers in Serum for the Prediction of Metastases Development in Breast Cancer Patients: A Cohort Study [J].
Kasoha, Mariz ;
Findeklee, Sebastian ;
Nigdelis, Meletios P. ;
Schmidt, Gilda ;
Solomayer, Erich-Franz ;
Hamoud, Bashar Haj .
BIOMEDICINES, 2024, 12 (06)
[27]   Biochemical markers of bone turnover in patients with spinal metastases after resistance training under radiotherapy – a randomized trial [J].
Harald Rief ;
Georg Omlor ;
Michael Akbar ;
Thomas Bruckner ;
Stefan Rieken ;
Robert Förster ;
Ingmar Schlampp ;
Thomas Welzel ;
Tilman Bostel ;
Heinz Jürgen Roth ;
Jürgen Debus .
BMC Cancer, 16
[28]   Biochemical markers of bone turnover in patients with spinal metastases after resistance training under radiotherapy - a randomized trial [J].
Rief, Harald ;
Omlor, Georg ;
Akbar, Michael ;
Bruckner, Thomas ;
Rieken, Stefan ;
Foerster, Robert ;
Schlampp, Ingmar ;
Welzel, Thomas ;
Bostel, Tilman ;
Roth, Heinz Juergen ;
Debus, Juergen .
BMC CANCER, 2016, 16
[29]   Clinical outcome for small cell lung cancer patients with bone metastases at the time of diagnosis [J].
Gong, Linlin ;
Xu, Liming ;
Yuan, Zhiyong ;
Wang, Zhongqiu ;
Zhao, Lujun ;
Wang, Ping .
JOURNAL OF BONE ONCOLOGY, 2019, 19
[30]   Oral ibandronate is as active as intravenous zoledronic acid for reducing bone turnover markers in women with breast cancer and bone metastases [J].
Body, J.-J. ;
Lichinitser, M. ;
Tjulandin, S. ;
Garnero, P. ;
Bergstroem, B. .
ANNALS OF ONCOLOGY, 2007, 18 (07) :1165-1171
12345